Advertisements



Alnylam announces alignment on value-based agreements for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam announces alignment with FDA on Phase 3 study for lumasiran

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 3rd, 2018

Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2018

Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2018 Veloxis upgrades 2018 Outlook based on strong performance PR .....»»

Category: earningsSource: benzingaAug 13th, 2018

Alnylam Pharmaceutical"s (ALNY) Conference Call to Discuss FDA Approval of ONPATTRO (Patisiran) - Slideshow

Alnylam Pharmaceutical"s (ALNY) Conference Call to Discuss FDA Approval of ONPATTRO (Patisiran) - Slideshow.....»»

Category: topSource: seekingalphaAug 13th, 2018

Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic

Alnylam (ALNY) receives FDA approval for Onpattro to treat polyneuropathy of hereditary transthy.....»»

Category: dealsSource: nytAug 13th, 2018

Alnylam rare drug gets FDA approval, to cost $345,000 on average

Alnylam Pharmaceuticals Inc.'s rare disease drug Onpattro has been approved by the Food and Drug Administration, marking the first approval of a therapy that employs the RNA interference (RNAi) gene-silencing technique. Onpattro, also called patis.....»»

Category: topSource: marketwatchAug 11th, 2018

Alnylam rare drug gets FDA approval, to cost $345,000 on oaverage

Alnylam Pharmaceuticals Inc.'s rare disease drug Onpattro has been approved by the Food and Drug Administration, marking the first approval of a therapy that employs the RNA interference (RNAi) gene-silencing technique. Onpattro, also called patis.....»»

Category: topSource: marketwatchAug 10th, 2018

Alnylam expects Germany to be first EU launch country for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam says Onpattro to be available from two specialty pharmacies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam sees annual average list price before discounts of Onpattro of $450,000

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam tells Bloomberg will work with FDA to get broader claims for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam confirms FDA approves Onpattro to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam"s Onpattro approved by FDA to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

FDA approves Alnylam"s Onpattro as hATTR treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Welbilt"s Q2 Earnings Preview

Welbilt (NYSE: WBT) announces its next round of earnings Thursday. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Based on management's proje.....»»

Category: earningsSource: benzingaAug 8th, 2018

Axon announces strategic agreements with Verizon, AT&T

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 8th, 2018

Dean Foods Q2 Earnings Preview

Dean Foods (NYSE: DF) announces its next round of earnings Tuesday. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Based on Dean Foods management projections, analys.....»»

Category: earningsSource: benzingaAug 6th, 2018

On Deck Capital Q2 Earnings Preview

On Deck Capital (NYSE: ONDK) announces its next round of earnings this Tuesday. Here's Benzinga's advanced look at On Deck Capital's Q2 earnings report. Earnings and Revenue Based on management's.....»»

Category: earningsSource: benzingaAug 6th, 2018

Sally Beauty Q3 Earnings Preview

Sally Beauty Holdings (NYSE: SBH) announces its next round of earnings Thursday. Here is Benzinga's everything-that-matters guide for the Q3 earnings announcement. Earnings and Revenue Based on Sally Beaut.....»»

Category: earningsSource: benzingaAug 1st, 2018

Alnylam announces CHMP recommends marketing authorization of patisiran

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 27th, 2018

A Preview Of Mohawk Industries" Q2 Earnings

Mohawk Industries (NYSE: MHK) announces its next round of earnings Wednesday. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Based .....»»

Category: earningsSource: benzingaJul 25th, 2018